EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell Transplantation

Miguel Mansilla-Polo iD, Juan Montoro iD, Javier López-Davia, Aitana Balaguer-Rosello, Marta Villalba-Montaner, Pedro Chorão, Pedro Asensi iD, Javier De la Rubia iD, Blanca de Unamuno-Bustos, Daniel Martín-Torregrosa iD, Carlos Abril-Pérez iD, Vicent Martínez-Cózar und 4 weitere

International Journal of Dermatology · 2025

DOI: 10.1111/ijd.70195 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Miguel Mansilla-Polo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Keratosis, Actinic, Hematopoietic Stem Cell Transplantation, Skin Neoplasms, Basal Cell Carcinoma. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients undergoing hematopoietic stem cell transplantation (HSCT) are at an increased risk of secondary skin neoplasms. However, detailed clinicopathological and therapeutic descriptions are limited.

Methods

We conducted a prospective, observational, single‐center study including HSCT recipients. Patients with actinic keratosis or skin/mucosal malignancies were evaluated by expert dermatologists, with a histological review. Management followed standard protocols, and patients were stratified according to the National Comprehensive Cancer Network (NCCN) guidelines.

Results

Of the 2042 HSCT recipients, 96 (4%) developed any actinic keratosis or skin cancer, with a median latency period of approximately three years. The most common lesions were basal cell carcinoma (BCC, 35%), actinic keratosis (30%), and squamous cell carcinoma (SCC, 22%), followed by melanoma (9%). The lesions predominantly appeared on the face and scalp. Almost 20% of invasive SCCs or BCCs exhibited high‐risk histopathological features, most commonly micronodular BCC and deep invasion in SCC. Surgical excision was the primary treatment; however, a high percentage of positive margins was found, especially in SCCs. At follow‐up, 47% of patients developed subsequent lesions, typically of the same histological subtype or actinic keratosis, with a median time to recurrence of 9.5 months. One patient died from metastatic SCC of the lip.

Conclusion

This study provides the most detailed clinicopathological description of post‐HSCT cutaneous lesions to date. While most tumors were non‐aggressive, the high prevalence of high‐risk features and recurrence highlights the need for dermatological surveillance. Nearly half of patients develop new lesions within months of the first diagnosis, so regular follow‐up is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Keratosis, ActinicHematopoietic Stem Cell TransplantationSkin NeoplasmsBasal Cell CarcinomaNeoplasms, Second PrimaryMelanomaCarcinoma, Squamous CellHumansFemaleMaleProspective StudiesAgedCutaneous Squamous Cell CarcinomaMiddle AgedNeoplasm Recurrence, LocalAdultAged, 80 and over

Stichwörter der Autor:innen

hematopoietic stem cell transplantationsecondary malignanciessecondary skin cancer

Autor:innen und Institutionen

  • Dermatology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain.
  • Department of Medicine, University of Valencia., Valencia, Spain.
  • Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • School of Medicine and Dentistry, Catholic University of Valencia, Valencia, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain.

ORCID-Profile: Miguel Mansilla-Polo, Juan Montoro, Pedro Asensi, Javier De la Rubia, Daniel Martín-Torregrosa, Carlos Abril-Pérez

Zitieren

APA

Mansilla-Polo, M., Montoro, J., López-Davia, J., Balaguer-Rosello, A., Villalba-Montaner, M., Chorão, P., Asensi, P., De la Rubia, J., de Unamuno-Bustos, B., Martín-Torregrosa, D., Abril-Pérez, C., Martínez-Cózar, V., Llavador-Ros, M., Sanz, M. Á., Botella-Estrada, R., & Sanz, J. (2025). Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell Transplantation. International Journal of Dermatology. https://doi.org/10.1111/ijd.70195

Vancouver

Mansilla-Polo M, Montoro J, López-Davia J, Balaguer-Rosello A, Villalba-Montaner M, Chorão P, et al. Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell Transplantation. International Journal of Dermatology. 2025. doi:10.1111/ijd.70195

BibTeX
@article{MansillaPolo2025,
  author = {Mansilla-Polo, Miguel and Montoro, Juan and López-Davia, Javier and Balaguer-Rosello, Aitana and Villalba-Montaner, Marta and Chorão, Pedro and Asensi, Pedro and De la Rubia, Javier and de Unamuno-Bustos, Blanca and Martín-Torregrosa, Daniel and Abril-Pérez, Carlos and Martínez-Cózar, Vicent and Llavador-Ros, Margarita and Sanz, Miguel Ángel and Botella-Estrada, Rafael and Sanz, Jaime},
  title = {Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell Transplantation},
  journal = {International Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ijd.70195}
}
Kostenlos starten →